Patients with symptomatic (New York Heart Association [NYHA] class III or IV) systolic (left ventricular ejection fraction [LVEF] ≤40%) congestive heart failure (CHF) were randomized to ...
Since most of the clinical trials of -blocking agents have been conducted in patients with heart failure NYHA functional class II/III, until recently there was limited information regarding safety ...
In the subgroup of patients with NYHA class III heart failure, there was a relative 44% increase in the risk of death among patients receiving amiodarone compared with placebo. 9 Such a finding ...
symptoms of NYHA class 3–4 heart failure, and low ejection fraction associated with mild left ventricular dilation, among other signs of heart dysfunction. Transmission electron micrographs of ...
NYHA class at baseline was II in 23% of patients, III in 57%, and IV in 16%. Most patients had hypertension (84%), 32% had ...
PASCAL repair offers lasting TR reduction, better survival, and improved quality of life in severe tricuspid regurgitation.